Detalles de la búsqueda
1.
Epitope specificity of two anti-morphine monoclonal antibodies: In vitro and in silico studies.
J Mol Recognit
; 33(9): e2846, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32219918
2.
Crystal structures of CDC21-1 inteins from hyperthermophilic archaea reveal the selection mechanism for the highly conserved homing endonuclease insertion site.
Extremophiles
; 23(6): 669-679, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31363851
3.
Safety, efficacy, and biological data of T cell-enabling oncolytic adenovirus TILT-123 in advanced solid cancers from the TUNIMO monotherapy phase I trial.
Clin Cancer Res
; 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38546220
4.
An oncolytic adenovirus coding for a variant interleukin 2 cytokine improves response to chemotherapy through enhancement of effector lymphocyte cytotoxicity, fibroblast compartment modulation and mitotic slippage.
Front Immunol
; 14: 1171083, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37475863
5.
Oncolytic adenovirus coding for bispecific T cell engager against human MUC-1 potentiates T cell response against solid tumors.
Mol Ther Oncolytics
; 28: 59-73, 2023 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36699617
6.
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting.
Front Immunol
; 14: 1060540, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36817448
7.
Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer.
Oncoimmunology
; 12(1): 2241710, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37546696
8.
Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1.
Oncoimmunology
; 11(1): 2028960, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35083096
9.
Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer.
Front Immunol
; 13: 794251, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35355980
10.
Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression.
Oncoimmunology
; 11(1): 2096572, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35845722
11.
Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control.
Front Immunol
; 12: 674400, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34084172
Resultados
1 -
11
de 11
1
Próxima >
>>